Researchers developed molecules, called splice-switching oligonucleotides (SSOs) that bind to the RNA molecules encoding a protein known as REST. In neuroendocrine tumors, these RNAs are incorrectly ...

Earlier this year Splice launched a new mobile app called CoSo that used AI to build what it calls "Stacks" collections of samples that are supposed to work well together. Slowly but surely elements ...